F-18 flouro deoxyglucose SPECT for assessment of myocardial viability
- 1 July 2000
- journal article
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 7 (4) , 382-387
- https://doi.org/10.1067/mnc.2000.107821
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretationSeminars in Nuclear Medicine, 1996
- Present assessment of myocardial viability by nuclear imagingSeminars in Nuclear Medicine, 1996
- Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunctionThe American Journal of Cardiology, 1994
- Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomographyJournal of the American College of Cardiology, 1992
- Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularizationThe American Journal of Cardiology, 1992
- The effect of coronary artery bypass grafting on left ventricular systolic function at rest: Evidence for preoperative subclinical myocardial ischemiaThe American Journal of Cardiology, 1988
- Improved regional ventricular function after successful surgical revascularizationJournal of the American College of Cardiology, 1984
- Results of coronary artery surgery in patients with poor left ventricular function (CASS).Circulation, 1983
- METABOLIC TRAPPING AS A PRINCIPLE OF RADIO-PHARMACEUTICAL DESIGNJournal of Computer Assisted Tomography, 1979
- Post-extrasystolic potentiation of ischemic myocardium by atrial stimulationAmerican Heart Journal, 1978